ViiV Healthcare’s investigational broadly neutralising antibody – N6LS – successfully maintains viral suppression in long-acting treatment of HIV

FHS
March 13, 2025
10:18 am

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Envision Healthcare Bounces Back After Bankruptcy

Six months after filing for bankruptcy, the physician staffing firm Envision Healthcare has bounced back after extensive restructuring that cut the company’s debt by more

November 8, 2023

Weedology 101: College cannabis classes spring up across Massachusetts – The Cannabist

Related Articles Your old weed dealer may be giving lectures at a professor’s podium sometime soon. Colleges across the region are turning to the pot

May 3, 2023

Online app supports weight loss through protein and fiber tracking

Many people struggle to maintain a healthy weight, and choosing the optimal meals for weight loss can be challenging.

January 25, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.